Released on: November 9, 2007, 6:55 am

Press Release Author: Buzz121

Industry: Healthcare

Press Release Summary: NextGen have revealed that recent findings have concluded
that cancer stem cells are not simply malignant counterparts of normal stem cells.


Press Release Body: NextGen are apparently focusing their business model on recent
findings that cancer cells arise from progenitor cells that accumulate mutations in
the genes that otherwise regulate normal cell growth and differentiation. According
to groundbreaking research research, once the genes of cancerous have been altered,
this becomes a crucial factor in tumour initiation.

NextGen are said to be concentrating on establishing a comprehensive approach that
will enable a more targeted and accurate classification of malignant breast tumours
for patient stratification. NextGen believes that this approach will ensure the
development of tailor made personal treatment strategies aimed at effectively
treating breast cancer.

Web Site: http://www.bakerwilcox.co.uk/nextgen/

Contact Details: NextGen Bioscience, Inc
c/o MC Bio,
46 Aldgate High Street
EC3N 1AL London, U.K.
Attn. Graham May, Company Secretary

Phone: +44 (0)20 7377 6969
Fax: +44 (0)20 7377 9454

Email : info@nextgenbioscience.com